RAPT Therapeutics, Inc.RAPTNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank75
3Y CAGR+7.3%
5Y CAGR+12.7%
Year-over-Year Change
Research and development spending
3Y CAGR
+7.3%/yr
vs +20.5%/yr prior
5Y CAGR
+12.7%/yr
Recent deceleration
Acceleration
-13.2pp
Decelerating
Percentile
P75
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $82.87M | -22.7% |
| 2024 | $107.22M | +6.2% |
| 2023 | $101.00M | +50.6% |
| 2022 | $67.08M | +17.7% |
| 2021 | $56.98M | +25.3% |
| 2020 | $45.48M | +30.3% |
| 2019 | $34.91M | +9.9% |
| 2018 | $31.77M | +24.0% |
| 2017 | $25.62M | - |